2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches

Поділитися
Вставка
  • Опубліковано 5 лис 2024
  • From Total Health's 2022 University of Kansas Post San Antonio Review, we bring you a session focused on metastatic HER2 positive breast cancer presented by Dr. Sara Hurvitz from UCLA Health. In the session, Dr. Hurvitz covers novel treatment approaches including; Trastuzumab Deruxtecan in ifrst-line, TULIP Phase III, PHOEBE, and more.
    To obtain credit for this CME activity you must watch the full 2022 University of Kansas Post San Antonio Reivew Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.

КОМЕНТАРІ • 2